AOD‑9604 is a synthetic peptide fragment of human growth hormone (HGH 176‑191) that was originally researched as an anti‑obesity drug.
It is designed to selectively activate the fat‑burning pathways associated with growth hormone while avoiding its broader growth and blood‑sugar effects.
Clinical studies suggest AOD‑9604 can modestly enhance fat breakdown and support body composition when used alongside nutrition and lifestyle interventions.
It is not FDA‑approved for weight loss; use is based on practitioner discretion and current clinical evidence.
*AOD‑9604 is not a substitute for healthy nutrition, movement, or management of underlying medical conditions.
*Potential benefits are based on emerging evidence and clinical experience; individual results vary.
| UAE Made | Vegan Friendly | Gluten Free | Corn Free |
| Y | Y | Y | Y |
| Dairy Free | Soy Free | Shellfish Free | No Egg Products |
| Y | Y | Y | Y |
| Ingredient name | Description |
|---|---|
| AOD 2000mcg/mL | AOD‑9604 (HGH fragment 176‑191) |
AOD‑9604 (HGH fragment 176‑191) – dose per vial as compounded by partner pharmacy/clinic.
Sterile diluent and other compounding ingredients as per pharmacy specifications (preservatives and buffer agents may vary by batch).
Subcutaneous injection into fatty tissue (e.g., lower abdomen or outer thigh), using an insulin syringe, as instructed by a healthcare professional.
Timing & Frequency
Duration of Standard Course
Standard Dosing Increase
Common Side Effects and Adverse Reactions
Typically mild and transient where they occur:
Reactions Requiring Medical Attention
Patients should stop injections and contact their healthcare provider (or emergency services, if severe) if they experience:
Safety Note: Long‑term data are limited; use should always be monitored by a qualified clinician, with regular review of metabolic markers and overall treatment goals.